Harvard biologist Mandë Holford studies venomous snails and other toxic creatures to unlock new medications that may one day ...
Detailed results presented at a medical congress help reinforce analyst expectations the drug, called duvakitug, will be competitive with other Crohn’s, colitis medicines in testing.
A unique protein designed by Cedars-Sinai Cancer investigators can cross the protective blood–brain barrier safely and deliver therapy directly into cancerous tumor cells, a preclinical study shows.
Sloan Kettering is one of the world’s leading cancer centers. It was founded by two men who created and sold leaded gasoline ...
Mashack made a pair of free throws and Chaz Lanier hit a 3-pointer to give Tennessee a 33-30 lead, its first of the game. Zeigler warmed up after halftime with the intent to return, a Tennessee ...
Here’s how it works. Rocket Lab launched five "Internet of Things" satellites on Saturday (Feb. 8). A 59-foot-tall (18 meters) Electron rocket carrying five spacecraft for the French company ...
Donald Trump has announced that an atmospheric scientist at the center of the infamous “Sharpiegate” controversy will lead the National Oceanic and Atmospheric Administration. Jacobs was later ...
Vaccine makers: GSK (NYSE:GSK), Sanofi (NASDAQ:SNY), Pfizer (NYSE:PFE)/BioNTech (BNTX), Moderna (NASDAQ:MRNA), and Novavax (NVAX). Weight loss drugmakers: Novo ...
L’Oreal OR-1.27%decrease; red down pointing triangle will sell part of its stake in Sanofi SAN-0.21%decrease; red down pointing triangle back to the French pharmaceutical company for 3 billion ...
Sanofi has bought back a €3bn ($3.1bn) stake held by cosmetics giant L'Oréal, the first of multiple share buybacks the French drugmaker has planned for 2025. L'Oréal was selling 29,556,650 ...
AdvanCell has secured $112 million in a Sanofi Ventures-backed series C funding round as the Australian radiopharma company takes its lead candidate through a prostate cancer trial. The Pb-212 ...
Sanofi is planning a $5.12bn share buyback programme in 2025. Image credit: Shutterstock / JHVEPhoto. Sanofi has bought back a €3bn ($3.1bn) stake held by cosmetics giant L’Oréal, the first of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results